Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation (Q73140673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

Masaya Shigeno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Kazuhiko Nakao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Tatsuki Ichikawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Kasumi Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atsushi Kawakami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Seigou Abiru

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Seiji Miyazoe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Yuichi Nakagawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Hiroki Ishikawa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Keisuke Hamasaki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Keisuke Nakata

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Nobuko Ishii

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Katsumi Eguchi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1653-1662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642868%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206139

1 November 2019

exact match

0 references

cites work

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Survivin promotes cell proliferation in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206139

7 January 2021